Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Stylesson Jun 03, 2014 11:08pm

188 Views

Post# 22627467

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Fair market value over $7.00

you guys are such haters. Sounds like you're the dumbs that bought at 7.

It's okay...we'llget there in a few months/years.ha

i got into placement I, II and bought in the market like i said in the low 5s.

Suspect your cost base starts with a 5, 6, 7? ha

Bullboard Posts

Bitcoin Well increases reserve amid strong subscriber growth